One Compared with Two Cycles of Mitomycin C in Chemoradiotherapy for Anal Cancer: Analysis of Outcomes and Toxicity - Concepedia

Concepedia

Publication | Open Access

One Compared with Two Cycles of Mitomycin C in Chemoradiotherapy for Anal Cancer: Analysis of Outcomes and Toxicity

DOI Full Paper Access

28

Citations

15

References

2014

Year

Raymond S. Yeung, Yarrow J. McConnell, George Roxin, Rintu Banerjee‬‬‬‬‬‬‬‬‬, Gloria B. Roldán Urgoiti, Anthony R. MacLean, W. Donald Buie, Karen Mulder, Michael M. Vickers, Kurian Joseph,

Current Oncology

Abstract

In definitive chemoradiotherapy for acc, 1 cycle of mmc appears to offer outcomes similar to those achieved with 2 cycles, with significantly less acute toxicity.

References

	Year	Citations

Page 1